Pharmacy Consulting

Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

Learn More About PHSL Services

News & Events

Get Ready: Medicare Model Guidelines Version 9 Are Coming

Medicare Part D coverage for prescription drugs is a federal program that is administered via private entities.  Each approved Medicare Part D plan must offer at least a standard level of coverage.  The list of covered drugs, or formulary, must include at least 2 drugs in the most commonly prescribed categories and classes.  United States Read More →

FDA Novel Drug Approval Trends

Prescription drugs must be approved by the United States Food and Drug Administration (FDA) before entering the market. Each year, the FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approve a wide range of new drugs and biologics. These products can either be drugs that have never Read More →

PHSL to Attend the NASP 2023 Annual Meeting & Expo

PHSL Vice President Melissa Krause and Director of Business Development Karlo Zovko will be attending the National Association of Specialty Pharmacy (NASP) 2023 Annual Meeting & Expo on September 18-21 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas. According to NASP, the annual meeting offers 45 education sessions and six workshops. To schedule a Read More →

Latest from the Blog

Who Assigns Labeler Codes?

Prescription Drug Labeler Code Confusion often arises when evaluating what the labeler code is and who assigns it. When drugs are labeled, the first section of the NDC (National Drug Code) number is classified as the labeler code. Labeler codes are requested by the manufacturer and are required for any manufacturer or distributor who lists Read More →

Medical Devices and Digital Therapeutics: Many Ways to Get to Market

Most people know that for a prescription drug to be on the market, it must receive approval from the United States Food and Drug Administration (FDA). Did you know that many medical devices and Digital Therapeutics (DTx) are also approved and regulated by the FDA? What are medical devices and how are they different from Read More →

New FDA Guidance on the Test-to-Treat COVID-19 Anti-Virals

On December 22, 2021, the Federal Food and Drug Administration (FDA) made news headlines by issuing an emergency use authorization for the use of Pfizer’s ritonavir-boosted nirmatrelvir (Paxlovid) for the treatment of COVID-19. This was followed a day later by the emergency use authorization of Merck’s drug molnupiravir (Lagevrio), also for the treatment of COVID-19. Read More →